CD4 and glioblastoma: Similarly, to assess the correlation between the expression of c-Met and FasL on GSCs with peripheral circulating immune cells, PBMCs of the same glioblastoma patients and healthy controls were evaluated for CD4+, CD8+, and T reg (CD25 + FOXP3) through flow cytometry.